Brief: Tandem Diabetes Care’S Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared For Pregnancy In Type 1 Diabetes
27/04/2026 14:21
April 27 (Reuters) - Tandem Diabetes Care Inc TNDM.O: TANDEM DIABETES CARE’S CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY NOW FDA CLEARED FOR PREGNANCY IN TYPE 1 DIABETES Source text: ID:nBw8Wk66va Further company coverage: TNDM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary